These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 15260845)
1. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845 [TBL] [Abstract][Full Text] [Related]
2. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related]
3. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917 [TBL] [Abstract][Full Text] [Related]
5. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
7. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
9. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
10. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
11. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956 [TBL] [Abstract][Full Text] [Related]
12. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related]
13. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P; Zaravinos A; Zioga M; Spandidos DA Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278 [TBL] [Abstract][Full Text] [Related]
14. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636 [TBL] [Abstract][Full Text] [Related]
15. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
16. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621 [TBL] [Abstract][Full Text] [Related]
17. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302 [TBL] [Abstract][Full Text] [Related]
18. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus. Gilley J; Fried M Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876 [TBL] [Abstract][Full Text] [Related]
19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
20. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]